CYP4F12 Blocking peptide (C terminal region)

Description of Target: Hydroxylates arachidonic acid (20:4n-6) to (18R)-hydroxyarachidonate. Shows little activity against prostaglandin (PG) D2, PGE1, PGE2, PGF2alpha, and leukotriene B4. Catalyzes omega-2 and omega-3-hydroxylation of PGH1 and PGH2. Catalyzes epoxidation of 4,7,10,13,16,19-(Z)-docosahexaenoic acid (22:6n-3) and 7,10,13,16,19-(Z)-docosapentaenoic acid (22:5n-3) and omega-3-hydroxylation of 4,7,10,13,16-(Z)-docosapentaenoic acid (22:5n-6). Catalyzes hydroxylation of PGI2 and carbaprostacyclin.

Product Format: Lyophilized powder

Protein Size: 520

• Artikelnummer: AVIAAP96991-100
• Hersteller: Aviva Systems Biology
• Hersteller Artikelnummer: AAP96991-100UG
• Verpackungseinheit: 100µg
• Mengeneinheit: STK
• Methode: Western Blotting
• Human Gene ID: 66002